IRhythm Technologies Change in Accounts Receivable 2015-2025 | IRTC
IRhythm Technologies annual/quarterly change in accounts receivable history and growth rate from 2015 to 2025. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
- IRhythm Technologies change in accounts receivable for the quarter ending June 30, 2025 was $-0.057B, a 4.37% decline year-over-year.
- IRhythm Technologies change in accounts receivable for the twelve months ending June 30, 2025 was $-0.248B, a 4.48% increase year-over-year.
- IRhythm Technologies annual change in accounts receivable for 2024 was $-0.092B, a 13.21% increase from 2023.
- IRhythm Technologies annual change in accounts receivable for 2023 was $-0.081B, a 31.3% increase from 2022.
- IRhythm Technologies annual change in accounts receivable for 2022 was $-0.062B, a 15.43% increase from 2021.
| IRhythm Technologies Annual Change in Accounts Receivable (Millions of US $) |
|
|---|---|
| 2024 | $-92 |
| 2023 | $-81 |
| 2022 | $-62 |
| 2021 | $-54 |
| 2020 | $-38 |
| 2019 | $-29 |
| 2018 | $-22 |
| 2017 | $-12 |
| 2016 | $-9 |
| 2015 | $-1 |
| 2014 | $-3 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $5.243B | $0.592B |
| iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.412B | 59.05 |
| Tempus AI (TEM) | United States | $12.731B | 0.00 |
| Doximity (DOCS) | United States | $12.055B | 53.63 |
| Hims & Hers Health (HIMS) | United States | $9.805B | 80.33 |
| Hinge Health (HNGE) | United States | $4.466B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.752B | 40.46 |
| Privia Health (PRVA) | United States | $2.596B | 192.27 |
| Heartflow (HTFL) | $2.379B | 0.00 | |
| Enovis (ENOV) | United States | $1.715B | 9.06 |
| 10x Genomics (TXG) | United States | $1.663B | 0.00 |
| Phreesia (PHR) | United States | $1.648B | 0.00 |
| Omnicell (OMCL) | United States | $1.458B | 28.10 |
| Schrodinger (SDGR) | United States | $1.425B | 0.00 |
| Azenta (AZTA) | United States | $1.365B | 59.54 |
| Clover Health Investments (CLOV) | United States | $1.302B | 0.00 |
| Claritev (CTEV) | United States | $1.088B | 0.00 |
| Evolent Health (EVH) | United States | $1.052B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.654B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.568B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Standard BioTools (LAB) | United States | $0.470B | 0.00 |
| Talkspace (TALK) | United States | $0.430B | 128.50 |
| Butterfly Network (BFLY) | United States | $0.355B | 0.00 |
| Carlsmed (CARL) | United States | $0.320B | 0.00 |
| TruBridge (TBRG) | United States | $0.291B | 51.03 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.242B | 0.00 |
| Outset Medical (OM) | United States | $0.237B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.216B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.205B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.192B | 0.00 |
| CapsoVision (CV) | United States | $0.184B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.139B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.133B | 0.00 |
| CareCloud (CCLD) | United States | $0.112B | 5.08 |
| American Well (AMWL) | United States | $0.111B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.077B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.072B | 0.00 |
| 111 (YI) | China | $0.063B | 0.00 |
| Pulmonx (LUNG) | United States | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.039B | 0.00 |
| Precipio (PRPO) | United States | $0.024B | 0.00 |
| Zhongchao (ZCMD) | China | $0.022B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.009B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |